Furthermore, zelenirstat inhibits the myristoylation of ADP-ribosylation factor 6 (ARF6) in cultured colon cancer cells, and triggers ARF6 degradation (Pacylex, data on file). This evidence concerns the gene ARF6 and malignant colon neoplasm.